Streetbeat News

Analyst Ratings

IMAX

JP Morgan analyst David Karnovsky has maintained a Neutral rating on Imax (NYSE:IMAX) and lowered the price target from $20 to $17.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:39 pm

BGNE

NVS

JP Morgan has resumed coverage on BeiGene Ltd (NASDAQ:BGNE), issuing an Overweight rating with a price target of $185, citing the recent pullback as an investment opportunity. The firm highlights BeiGene's strong product pipeline, including the blood cancer drug Brukinsa and the PD-1 inhibitor Tevimbra, as key valuation supports. The recent regaining of Tevimbra's commercial rights from Novartis AG (NYSE:NVS) is seen as an incremental opportunity for BeiGene.

Portfolio Pulse from Vandana Singh

February 06, 2024 | 7:38 pm

VRTX

Cantor Fitzgerald analyst Olivia Brayer reiterated an Overweight rating on Vertex Pharmaceuticals (VRTX) and maintained a $440 price target.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:37 pm

CNK

JP Morgan analyst David Karnovsky maintains a Neutral rating on Cinemark Holdings (CNK) and lowers the price target from $18 to $16.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:36 pm

CHGG

JP Morgan analyst Doug Anmuth has maintained a Neutral rating on Chegg (NYSE:CHGG) and lowered the price target from $10 to $9.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:33 pm

NET

Financial analysis reveals a bearish sentiment among big money traders on Cloudflare (NYSE:NET), with 54% showing bearish tendencies in recent options trades. Despite this, the volume and open interest trends indicate a targeted price range of $30.0 to $100.0. Cloudflare's current trading volume is 1,851,022, with a slight price decrease of -0.09%, positioned at $80.75. Professional analysts have set an average price target of $92.25, with ratings ranging from Overweight to Market Outperform.

Portfolio Pulse from Benzinga Insights

February 06, 2024 | 7:31 pm

APD

JP Morgan analyst Jeffrey Zekauskas maintains an Overweight rating on Air Products & Chemicals (APD) but lowers the price target from $295 to $270.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:30 pm

EXPE

Mizuho analyst James Lee maintains a Neutral rating on Expedia Group (NASDAQ:EXPE) and raises the price target from $130 to $140.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:28 pm

PLTR

Mizuho analyst Matthew Broome maintains a Neutral rating on Palantir Technologies (PLTR) and raises the price target from $16 to $18.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:26 pm

GWW

JP Morgan analyst Patrick Baumann has maintained a Neutral rating on W.W. Grainger (NYSE:GWW) and increased the price target from $800 to $925.

Portfolio Pulse from Benzinga Newsdesk

February 06, 2024 | 7:26 pm